This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignee: Intra-Cellular Therapies, Inc.. Active years: 2024-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024-2025
Title: William Paul Findlay: Innovator in Pharmaceutical Dosage Forms
Introduction
William Paul Findlay is a notable inventor based in Massapequa, NY (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of solid oral dosage forms. With a total of 2 patents, his work focuses on innovative methods that enhance therapeutic efficacy.
Latest Patents
William Paul Findlay's latest patents involve methods related to solid oral dosage forms comprising lumateperone. These formulations can be in free or pharmaceutically acceptable salt form and may include one or more additional therapeutic agents. The processes for manufacturing these dosage forms and their methods of use in the treatment or prophylaxis of disease are also covered in his patents.
Career Highlights
William is currently associated with Intra-Cellular Therapies, Inc., where he continues to push the boundaries of pharmaceutical innovation. His work is instrumental in developing new treatment options that can significantly improve patient outcomes.
Collaborations
Some of his notable coworkers include Peng Li and Robert E. Davis. Their collaborative efforts contribute to the advancement of research and development in the pharmaceutical industry.
Conclusion
William Paul Findlay is a distinguished inventor whose work in solid oral dosage forms has the potential to transform therapeutic practices. His contributions to the field are invaluable and continue to pave the way for future innovations.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile